Price target
4.200.00 0.00%
The 4 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to ATRA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ATRA EPS for the last quarter is −0.56 USD despite the estimation of −0.45 USD. In the next quarter EPS is expected to reach −0.26 USD. Track more of Atara Biotherapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Atara Biotherapeutics, Inc. revenue is expected to reach 24.69 M USD. Check out Atara Biotherapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ATRA price target is 4.20 USD with a max estimate of 13.00 USD and a min estimate of 0.50 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ATRA news and stock market news.
We've gathered opinions of 5 analysts rating ATRA stock in the past 3 months. After counting all points of view, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.